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Abstract
Alstro ¨m syndrome (ALMS) is a progressive multi-systemic disorder characterized by cone-rod dystrophy, sensorineural
hearing loss, childhood obesity, insulin resistance and cardiac, renal, and hepatic dysfunction. The gene responsible for
Alstro ¨m syndrome, ALMS1, is ubiquitously expressed and has multiple splice variants. The protein encoded by this gene has
been implicated in ciliary function, cell cycle control, and intracellular transport. To gain better insight into the pathways
through which ALMS1 functions, we carried out a yeast two hybrid (Y2H) screen in several mouse tissue libraries to identify
ALMS1 interacting partners. The majority of proteins found to interact with the murine carboxy-terminal end (19/32) of
ALMS1 were a-actinin isoforms. Interestingly, several of the identified ALMS1 interacting partners (a-actinin 1, a-actinin 4,
myosin Vb, rad50 interacting 1 and huntingtin associated protein1A) have been previously associated with endosome
recycling and/or centrosome function. We examined dermal fibroblasts from human subjects bearing a disruption in ALMS1
for defects in the endocytic pathway. Fibroblasts from these patients had a lower uptake of transferrin and reduced
clearance of transferrin compared to controls. Antibodies directed against ALMS1 N- and C-terminal epitopes label
centrosomes and endosomal structures at the cleavage furrow of dividing MDCK cells, respectively, suggesting isoform-
specific cellular functions. Our results suggest a role for ALMS1 variants in the recycling endosome pathway and give us new
insights into the pathogenesis of a subset of clinical phenotypes associated with ALMS.
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Introduction
Alstro ¨m syndrome (ALMS; OMIM#203800) is a monogenic
disorder characterized by a combination of features including
obesity, insulin resistance, type 2 diabetes and retinal and cochlear
degeneration that progress as patients age. Patients also may
present with short adult stature, male hypogonadotrophic
hypogonadism, cardiomyopathy, and failure in pulmonary,
hepatic, and/or renal function [1]. ALMS is caused by disruptions
in the ALMS1 gene, which primarily have been truncating
mutations located downstream of intron 7 [2,3,4]. ALMS1 is
a ubiquitous protein that localizes to centrosomes and basal bodies
of ciliated cells [5,6,7]. Like many other genes, ALMS1 expresses
a number of splice variants. Although the splicing patterns and
functions of ALMS1 are not fully understood, previous studies have
suggested roles for the protein in intracellular trafficking and
ciliary function [6,7,8,9]. To gain insight into the molecular
pathways in which ALMS1 is involved, we performed a yeast-two-
hybrid (Y2H) screen in three mouse tissue libraries using a bait
specific for the murine C-terminus of ALMS1. a-Actinin as well as
other members of the endosome recycling pathway were identified
as direct interactors with ALMS1.
Endocytosis entails a process by which cell surface receptors
facilitate the internalization of extracellular material such as
proteins and lipids in response to external cues [10,11]. The
endosomal recycling of such internalized receptors back to the
plasma membrane (PM) provides an efficient way to rapidly
replenish required receptors at the cell’s surface [12]. Several
mechanisms exist including a fast recycling route in which cargo
proteins are trafficked directly from early endosomes to the PM
and a slower recycling route in which cargo proteins are
transported from the early endosomes to an endosomal recycling
compartment (ERC) before recycling back to the PM [13]. Some
molecules like the transferrin receptor (TfR) utilize both types of
recycling pathways [14].
In recent years, a growing number of genes involved in
membrane and/or endosomal trafficking have been implicated in
Mendelian diseases including Griscelli’s syndrome, Charcot-
Marie-Tooth disease, Huntington’s disease and Lowe’s syndrome
[15,16]. Interestingly, fibroblasts from patients with Lowe’s
syndrome display structural abnormalities of the actin cytoskeleon
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actin filaments [17]. Previous studies have identified a-actinin as
a component of the CART (cytoskeleton-associated recycling or
transport) complex necessary for the recycling of receptors from
early endosomes to the plasma membrane (PM) [18,19].
Endosomes also play an important role during cell division in
mammalian development. During metaphase, early endosomes
(EE) are distributed throughout the cytoplasm. At this stage in cell
division, endocytic trafficking is significantly reduced [20].
Following mitosis, the cell membrane ingresses during cytokinesis
forming a bridge between the resulting daughter cells; a process
that is driven by a constricting ring assembly (contractile ring)
composed of the filamentous protein actin and the motor protein
myosin II. Recycling endosomes traffic crucial lipid and
membrane components to the cleavage furrow mediated by
a RAB11-FIP3 complex [21,22,23].
A role for an ALMS1 isoform in endosome recycling is
supported by our identification of ALMS1-interacting proteins
that have previously been associated with the recycling pathway.
In this study, we examine the distribution of ALMS1 and
endocytic components in vitro and demonstrate that a variant of
ALMS1 physically and spatially associates with a-actinin.
Furthermore, we demonstrate that the uptake and export of
transferrin, a molecule that undergoes endosome recycling, is
impaired in ALMS.
Results
Identification of proteins interacting with the C-terminal
end of ALMS1
To identify potential interactors of ALMS1, we used the Y2H
system to screen three murine tissue libraries (adult eye, adult
brain and 8.5 day embryo). Since the majority of mutations in
both ALMS patients and mouse models reside in exons 8, 10 and
16, we used the carboxy-terminal region of mouse ALMS1
(ALMS1-C1) as bait (Fig. 1A). The same construct was transferred
to a bacterial expression plasmid and its expression was induced in
E.coli. Using Invitrogen’s Lumio technology, a correctly-sized band
representing the induced ALMS1-C lumio fusion protein was
detected under fluorescent light (Fig. 1B.). In addition, a western
blot of the fusion protein probed with anti-ALMS1-C antibody
confirmed the specificity of the antibody (Fig. 1C).
In the Y2H experiments, 50 mM 3AT SC-Leu-Trp-His
inhibited growth of yeast transformed with DB-X (pDEST32-
Alms1) and AD-Y (pEXP-AD502 control) plasmids and, thus, was
selected as the concentration for all three tissue library screens. A
total of 40 clones re-grew after replica cleaning and were selected
for further analysis. To identify the prey proteins, the plasmids
were isolated, transformed into E. coli and grown on ampicillin
selection media. After purification, the plasmids were sequenced
and prey proteins were identified by comparison to the GenBank
Database using the BLAST search engine. Thirty-three of the
forty clones (82.5%) were successfully transformed and sequencing
revealed that 32/33 clones contained in frame coding sequences.
In the screen of the adult eye library, all of the sequenced clones
contained a-actinin isoforms 1–4, with ACTN4 clones being the
most frequently observed (Table 1). In the adult brain screen,
several clones of a-actinins 1 & 4, Huntington-associated protein,
isoform A (HAP1A), and Rab interacting lysosomal protein-like 1
(RILPL1) were isolated. In addition, single clones of Myosin Vb
(MYO5B), EXOSC8, ring finger protein 31 (RNF31) and RAD50
interactor 1 (RINT1) were identified. In the 8.5 day embryonic
library screen, we identified several clones of the CBP interacting
protein 3 (CIP3 or EXOSC8), one clone carrying a-actinin 1, and
a Riken clone 2700067D09 containing a hypothetical sterile alpha
motif (SAM) domain.
Confirmation of direct interactions of ALMS1 with
positive prey clones
Select prey plasmids were re-transformed into MAV203 with
bait (pDBLeu-Alms1) and without bait (pDBLeu only). Several bait
(Alms1) and prey (Actn1, Actn4, Myo5b, Exosc8, Hap1, Rnf31, Rint1)
complexes were subjected to growth tests in SC-LT plates lacking
uracil and SC-LT plates containing 50 mM 3AT. Cell growth was
examined after 3 days of incubation at 37uC (Table1). In addition,
these potential interactors were assessed by examining the length
of time required for detection of lacZ positive (blue) staining
(Fig. 1D). Actn1, Actn4, Myo5b, and Rint1 containing yeast cells
showed the strongest interaction as lacZ staining appeared within
the first two hours while Hap1 containing cells demonstrated
a weak interaction, with positive blue staining appearing only after
an overnight incubation.
Mapping the ALMS1 and a-actinin interaction domains
To further characterize the interaction domains of ALMS1 and
a-actinin, we made truncated Alms1 constructs cloned in pDBLeu
vector (Alms1C2: nts 8047–8802 & Alms1C3: nts 8962–9756) and
performed direct interaction tests in yeast. The Alms1C2 construct
contained the putative nuclear localization signals while the
Alms1C3 construct included the ALMS1 motif [2]. Figure 2A
shows that ACTN1 interacted most strongly with Alms1C3 while
an interaction with Alms1C2 was much weaker. Sequence
alignments to find common regions of overlap between Actn1
and Actn4 prey clones and the four a-actinin family members (1–4)
were performed. While none of the a-actinin clones contained the
actin binding domain, all clones had three of the four spectrin
repeats and both EF hands (Fig. 2B). However, sequence
differences were found at the carboxy terminal end of the EF
hand1 domain. While some a-actinin clones included the non-
muscle (NM) subtype, others had the smooth muscle (SM) subtype
indicating that this region may not be important for their binding
to ALMS1.
ALMS1 co-localizes and physically interacts with a-actinin
in mammalian cells
To determine whether ALMS1 and a-actinin interact in vivo, we
examined their distribution in Madin-Darby Canine Kidney
Epithelial (MDCK) cells (Dr. Guillaume Charras, University
College London). Immunostaining using antisera raised against a-
actinin 1 and the C-terminal end of mouse ALMS1 (ALMS1-C)
revealed that both proteins co-localize to dense bodies within the
cytoplasm (Fig. 3A–D). To validate the physical interaction of
ALMS1 with a-actinin, we performed a co-immunoprecipitation
assay using mouse kidney lysate. After precipitation of tissue lysates
with ALMS1-C and IgG antibody, samples were examined by
western analysis using an antibody for a-actinin 4. As shown in
Fig. 3E, ALMS1 co-immunoprecipitated with ACTN4 in whole
kidney lysates, confirming their direct interaction in mammalian
tissue.
Fibroblasts from ALMS patients show abnormalities in
actin stress fiber morphology
Because a-actinin is involved in the crosslinking of actin
filaments to focal adhesion sites, we assessed by immunofluores-
cence, the cytoskeletal architecture of actin stress fibers in patient
fibroblasts using FITC-conjugated phalloidin and an antibody
raised against ACTN4 (Fig. 4). Similar to controls, ALMS
ALMS1 Interacts with a-Actinin
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had nonuniform cross filaments. In addition, a subset of patient
fibroblasts showed punctate F-actin staining around the nuclear
periphery, underscoring the presence of shortened actin filaments.
Co-staining with ACTN4 showed that a-actinin distributes along
the actin stress fibers and at the focal adhesion sites in both patient
and control fibroblasts.
ALMS fibroblasts undergo ciliogenesis
Recently, Rab GTPases, regulators of endosomal trafficking, as
well as other endocytic proteins, have been shown to have roles in
ciliary assembly and trafficking [24,25,26]. Since ALMS1 has
implicated roles in ciliogenesis and/or ciliary function [6,7,9,27],
we sought to examine both ciliary axonemes and endosomes
during ciliogenesis by co-staining ALMS fibroblasts with fluores-
cently-labeled acetylated a-tubulin and an early endosomal
marker, EEA1 (Fig. 5). The cytoplasmic distribution of EEA1
and arrangement of microtubules were comparable in patient and
control fibroblasts. Furthermore, primary cilia were observed in
fully differentiated ALMS fibroblasts and controls (Fig. 5E,J).
Fibroblasts from ALMS patients show deficits in
transferrin trafficking
Transferrin (Tf) and its receptor, regulators of iron homeostasis,
are commonly used to assess for deficits in endocytosis and
endosomal recycling. Since earlier studies have shown that a-
actinin-4 and its interaction with components of the CART
complex are necessary for the efficient recycling of the transferrin
receptor from early endosomes to the PM [18], we sought to
determine whether ALMS1 may also have a role in Tf trafficking.
We pulsed fibroblasts with unlabelled Tf and examined the
distribution of its receptors in early and recycling endosomes by
immunostaining with endosomal markers EEA1 (early endosomes)
and RAB11 (recycling endosomes) (Fig. 6 A–L). In fibroblasts from
ALMS patients and controls, TfR was found scattered peripherally
and concentrated in a discrete cluster in the perinuclear area.
Many of these clustered receptors co-localized with RAB11,
a GTPase that is enriched in the pericentrosomal endosomal
recycling compartment (ERC) [28]. Immunostaining the fibro-
blasts with the centrosomal marker, pericentrin, confirmed the
pericentrosomal location of these TfR clusters (Fig. 6 M–N) and
demonstrated a proper positioning of the ERC in both control and
ALMS fibroblasts. The amount of TfR staining around the
centrosome was variable between fibroblasts. Therefore, we
measured the mean fluorescent intensities of TfR at the
pericentrosomal ERC (2 mM diameter area) in patient and control
fibroblasts (Fig. 6 O–Q). Mean Cy3-fluorescent intensities were
significantly higher in patient fibroblasts compared with controls
(p,0.0001) indicating a greater accumulation of TfR at the
pericentrosome.
To determine whether the loss of functional ALMS1 impairs the
rate of uptake and recycling of transferrin, we used FACS analysis
to measure the pulse-chase clearance of Tf in control and ALMS
fibroblasts. ALMS fibroblasts showed a slight but consistent 5–
10% reduction in the initial 30 minute uptake of labeled Tf (not
shown). A chase incubation with holo-transferrin at 37uC for 15,
30, and 60 minutes showed that the exit of Tf-Alexa 647 from the
recycling compartment was significantly delayed in ALMS
fibroblasts compared to controls (Fig. 6R), indicating an impair-
ment in the intracellular trafficking and recycling of endocytosed
transferrin.
Differential localization of ALMS1 isoforms during
cytokinesis
Cytokinesis is dependent on the delivery of membrane
components to the cleavage furrow. Such events are thought to
Figure 1. Yeast two hybrid analysis of ALMS1. (A) Alms1-C-terminal bait used for yeast two hybrid. (B) Bacterial induction of ALMS-C lumio
fusion protein reveals a 55 kDa band of expected size. B=Benchmark fluorescent ladder (Invitrogen); P=pellet; S=supernatant (C) Immunoblot using
anti-ALMS-C antibody shows specificity of the bacterially expressed protein to ALMS1, as indicated by blue coloration. (D) Y2H analysis reveals protein
interactors with mouse ALMS1 (carboxy-terminal end).
doi:10.1371/journal.pone.0037925.g001
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the cleavage furrow [21]. To investigate whether ALMS1 may
have a role in endosome recycling during cytokinesis, we
examined the staining pattern of ALMS1 by using antibodies
raised against the N-terminal (ALMS1-Ntr) and C-terminal
(ALMS1-C) ends, respectively, in MDCK cells undergoing late
cytokinesis. As expected, ALMS1-Ntr localized to the centrosomal
spindle poles throughout mitosis (not shown) and cytokinesis
(Fig. 7A). However, ALMS1-C localized to both the acto-myosin
contractile ring and to the cleavage furrow during both early and
late cytokinesis (Fig. 7B–C).
Discussion
In this study, we identified several binding partners of ALMS1-
C including the a-actinins and other components of the endosome
recycling pathway. a-actinin is a ubiquitously-expressed, cytoskel-
etal actin-binding protein with four known isoforms. a-actinin 1
and 4 are present in non-muscle cells along actin filaments and at
adhesion sites while a-actinin 2 and 3 are predominantly found in
muscle cells at the Z-disk junctions and surrounding bodies. The
a-actinin members play an important role in the organization of
the actin cytoskeleton by crosslinking actin filaments and linking
signaling peptides. In our study, the spectrin repeats and EF hands
of a-actinin appeared important in its interaction with ALMS1.
The spectrin repeats are found within the central rod region of a-
actinin and facilitate dimerization of the homodimer. This domain
also has important interaction sites for various cytoskeletal and
signaling molecules. The EF hands are found within the
calmodulin-like domain and interact with sm-titin, a polypeptide
important in the contraction of muscle tissue [29,30]. Sequence
analysis of a-actinin clones revealed that ACTN1 and ACTN4
isoforms contained either SM or NM subtypes in EF hand1 [31].
ACTN4 binds to non-muscle filamentous actin and has been
shown to be associated with macropinosomes and phagosomes
[32]. Since, in our study, the actin-binding domain of a-actinin
was not involved in ALMS1 binding, it would be available for
interaction with actin, suggesting that a-actinin might act as a link
between ALMS1 and the actin cytoskeleton.
Interestingly, two ALMS1 binding partners, ACTN4 and
MYO5B, are subunits of the cytoskeleton-associated recycling or
transport (CART) complex [18]. The CART complex is an
Figure 2. Y2H interaction domains of ALMS1 and a-actinin. (A) Direct interaction tests with truncated ALMS1 constructs reveals that both
constructs were sufficient for the interaction with a-actinin. However the most C-terminal construct showed the strongest interaction. (B) Alignments
of a-actinin 1 & 4 prey clone sequences from all three library screens. Potential ALMS1-interacting domains include the central rod and CaM-like
domains. The number of clones identified with each unique actinin prey sequence is shown in parentheses. CH=calponin homology; SR=spectrin
repeat; CaM=calmodulin-like; NM-nonmuscle; SM=smooth muscle.
doi:10.1371/journal.pone.0037925.g002
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and MYO5B proteins. MYO5B interacts with the Rab GTPase,
RAB11A and OPTN (FIP2) to regulate the endosomal recycling of
plasma membrane proteins [33,34,35,36]. The CART complex is
thought to be involved in the constitutive recycling of receptors,
such as the TfR and beta(2)-adrenergic receptor from early
endosomes to the PM via a fast recycling route [18,19]. Disruption
of the CART complex has been shown to inhibit TfR recycling in
HeLa cells [18]. In our study, fibroblasts from patients with ALMS
had a reduced ability to internalize and clear Tf suggesting an
impairment in the trafficking and recycling of transferrin.
Furthermore, structural alterations in F-actin were observed in
ALMS fibroblasts. This, along with the earlier finding of ALMS1
binding to actinin, leads us to speculate that in ALMS, the
aberrant recycling may be due to a disruption in the complex
cytoskeletal architecture that enables endosome recycling. Perhaps
ALMS1 is a component of the transport machinery that forms
a subcomplex with CART subunits and facilitates the rapid
movement of endosomes along the actin filaments to the PM. In
this scenario, the reduction in recycling rate in ALMS fibroblasts
may be the result of a diversion of Tf trafficking from the fast to
the slow recycling pathway.
Deficits in ciliary and centrosomal function have been reported
in ALMS [6,7,9,27]. However, the mechanism leading to the
pathology observed in ALMS remains unclear. Here, we show that
during cytokinesis, the spatial distribution of individual ALMS1
isoforms differ within the cell. Throughout cell division, an amino-
terminal-specific ALMS1 isoform localizes to the centriolar spindle
poles, while another variant, specifically labeled by an antibody
raised against a C-terminal ALMS1 domain, is found at the
cleavage furrow of dividing cells at a region commonly associated
with recycling endosomal clusters. Previously, Knorz et al [27]
identified two potential centrosome-targeting regions in ALMS1
and concluded that the C-terminal ALMS motif was not critical
for targeting to the centrosome. The C-terminal antibody did not
label the centrosome suggesting that this isoform lacks a centro-
some-targeting region. Our data also suggest that two distinct
ALMS1 isoforms may have diverse functions at the centrosome
and cleavage furrow, respectively.
In a recent report, ALMS fibroblasts had a slower rate of cell
proliferation when compared to control fibroblasts suggesting
a role for ALMS in cell division [37]. During cell division when the
Figure 3. ALMS1 interacts with a-actinin in mammalian cells.
(A–D) Co-localization of a-actinin (A) and ALMS1-C (B) in MDCK cells.
Both proteins are expressed within cytoplasmic dense bodies. Antibody
overlay and orthogonal projection are shown in C & D, respectively.
Scale bar=5 mm. (E) Co-immunoprecipitation of ALMS1 and actinin
from renal lysates of C57BL/6Ei mice. Lysates were incubated overnight
with a C-terminal ALMS1 antibody (polyclonal rabbit) and the
precipitated proteins were probed with anti-ACTN4 (polyclonal rabbit)
antibody.
doi:10.1371/journal.pone.0037925.g003
Figure 4. F-actin staining in fibroblasts. (A,E) Staining with anti-ACTN4 (red) in control and patient fibroblasts show actinin staining along stress
fibers and at focal adhesions. (B–C,E–F) F-actin stress fibers were visualized by staining with FITC-conjugated phalloidin at lower (206: B–E) and higher
(1006: C,F) magnifcations. Long densely packed fibers were observed in both samples, however, nonuniform and stunted filaments (white
arrowhead) were noted in ALMS fibroblasts. Co-staining with anti-ACTN4 (red) and FITC-phalloidin (green) show actinin staining along the stress
fibers (inset) and focal adhesions (white arrows) in both patient and control fibroblasts. Scale bars=10 mm (a,c,d,e,g,h); 100 mm (b,f).
doi:10.1371/journal.pone.0037925.g004
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actinin, myosin, and rab11 are trafficked to the cleavage site for
the delivery of crucial membrane and protein components
[23,38,39]. The distribution of ALMS1 at the cleavage furrow in
fibroblasts during cytokinesis suggest that one of the ALMS1
Figure 5. Immunostaining of microtubules and endosomes in ALMS fibroblasts. (A–D, F–I) Patient and control fibroblasts are stained with
EEA1 (green, early endosomal marker) and acetylated a-tubulin (red, microtubule markers). Panels E & J show formation of primary cilia in
differentiated fibroblasts from patients and controls. Scale bars=25 mm.
doi:10.1371/journal.pone.0037925.g005
Figure 6. Kinetics of transferrin recycling in ALMS and control fibroblasts. (A–L) ALMS and control fibroblasts were incubated with
unlabelled transferrin for 30 minutes. TfR and nuclei are depicted in red and blue, respectively. Early and recycling endosomes were immunostained
with Alexa Fluor 488-labelled EEA1 (A–F) and Rab11 (G–L), respectively. Scale bars=25 mm. (M–N) Co-localization with pericentrin (PCTN;red) and TfR
(green) shows overlay at the pericentrosome. (O–Q) Quantification of TfR and its colocalization with Rab11 at the pericentrosome. Mean fluorescence
intensity per 2 mm diameter area (dashed circle) was measured by ImageJ/Fiji software and used as an estimate of the number of TfR positive
endosomes. Results are from 40 patient and 47 control cells and error bars indicate 6 SEM; Star indicates p,0.0001. Scale bars=5 mm. (R) Cells were
‘pulsed’ with Tf-Alexa Fluor 647 for 30 min, followed by a ‘cold chase’ of unlabelled holo-transferrin for indicated times. Data was pooled from three
fibroblast cell lines from ALMS and control subjects. The graph represents the mean +/2 SEM of four independent experiments as a mean percentage
of Tf internalization at each time point. The values (MFI) obtained at time 0 following the pulse were set at 100%. Star denotes p,0.0001.
doi:10.1371/journal.pone.0037925.g006
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components to the cleavage furrow.
Future studies will be necessary to establish whether deficits in
endocytic recycling may be linked to the metabolic alterations
observed in ALMS. One of the classic clinical hallmarks of ALMS
is the inability to clear glucose from circulation, and the
development of insulin resistance, which often leads to type 2
diabetes. It is, for example, possible that there may be deficits in
the trafficking of the glucose transporter GLUT4 (SLC2A4),
normally responsible for the uptake of glucose into adipose and
muscle. In a recent study, Talior-Volodarsky et al proposed that
ACTN4 may tether GLUT4-containing vesicles to actin filaments
[40]. Further investigation is needed to determine whether there is
a relationship between the insulin resistance in ALMS and
endocytic trafficking of GLUT4. In addition, HAP1 was identified
as a weak interactor with ALMS1 in our Y2H library screen.
HAP1 is a cytoplasmic protein that is ubiquitously expressed
across a number of tissues, including the hypothalamic neurons.
HAP1 interacts with a number of proteins such as tyrosine kinase
substrate (HRS) and has been implicated in intracellular traffick-
ing, scaffold protein assembly, and endocytic trafficking [41]. Also
intriguing, in respect to ALMS, is the role HAP1 is thought to play
in the hypothalamic mediation of feeding behavior by interaction
with B subunits of the GABA-A receptors which have been shown
to stimulate feeding in rodents [41].
In summary, we have demonstrated that ALMS1 interacts with
components of the CART complex including members of the
Actinin family. The cellular phenotype observed in patient
fibroblasts during TfR recycling underscores an important role
for ALMS1 in the endocytic recycling pathway. Future investiga-
tions into the possible impairment in recycling of additional
cargoes/receptors in ALMS models will be necessary to better
understand the disease pathology of each individual ALMS
phenotype in hopes of identifying more effective therapeutic
targets for intervention.
Materials and Methods
DNA Constructs
The 39 end of Alms1 (Alms1C1: nts 8377–9756) was PCR-
amplified from mouse brain cDNA using PFU DNA Polymerase
(Stratagene, La Jolla, CA) and was purified using a Qiaprep Spin
Miniprep kit (Qiagen, Valencia, CA). The product was subcloned
into a pENTR-D vector (Gateway Technology, Invitrogen,
Carlsbad, CA) and transformed in TOPO-electrocompetent cells
(Invitrogen, Carlsbad, CA). For Y2H screening, the Alms1C1
construct was moved to the pDEST32 destination vector using LR
Clonase Enzyme mix according to the manufacturer’s protocols
(Invitrogen, Carlsbad, CA). For bacterial expression, the construct
was moved to the pDEST160 destination vector (Invitrogen,
Carlsbad, CA). The latter yielded a fusion protein with a his/lumio
tag on the N- terminus (ALMS1-pDEST160-lumio). To purify the
bacterially-expressed proteins from the pelleted inclusion body, we
performed lysozyme digestion in B-Per Reagent (Pierce). Re-
striction enzyme analysis and sequencing was carried out on all
constructs to confirm proper sequence and orientation.
Bacterial expression
ALMS1-pDEST160-lumio was transformed into BL-Star cells
(Invitrogen, Carlsbad, CA) and induced with isopropyl b-D-1-
thiogalactopyranoside (IPTG). Proteins were extracted using B-per
reagent (Thermo Scientific Pierce, Rockford, IL) and separated by
electrophoresis on a 4–12% NuPage Bis-Tris gel (Invitrogen,
Carlsbad, CA). The induced lumio fusion protein was detected
with Lumio Green Detection reagent and Lumio In-Gel Detection
enhancer and the induced protein was visualized under a fluores-
cent illuminator. Specificity of the band for ALMS1 was confirmed
by enhanced chemiluminescence (ECL) detection using an affinity
purified rabbit anti-ALMS1 antibody specific for residues EAR-
LEEDSDVTSSSEEKAKE at the C-terminal end of mouse
ALMS1 (Affinity BioReagents, Golden, CO).
Yeast Two Hybrid
Y2H assays were performed using the Proquest Two-Hybrid
System with Gateway Technology (Invitrogen, Carlsbad CA). The
yeast strain utilized in these studies, MaV203, carried three
reporter genes: HIS3, URA3, and lacZ that allowed for selection
and/or detection of positive clones. The DB-X destination vector
(bait) contained LEU2, while the AD-Y activation domain vector
(prey) carried TRP1. To determine the basal levels of HIS
expression, yeast transformed with DB-X (pDEST32-Alms1) and
AD-Y (pEXP-AD502 control) plasmids were replica plated on SC-
Leu-Trp-His agar plates containing varying concentrations of
3AT. The 3AT concentration of 50 mM was selected for the
library screen as it inhibited growth. A random hexamer primed
cDNA library was constructed using polyA+ mRNA isolated from
eyes of C57BL/6J mice (Invitrogen, Carlsbad, CA). The cDNA
was ligated into the ppc86 vector. Screening of pDEST32-Alms1
(bait) was done using three mouse cDNA prey libraries: adult eye,
adult brain (Invitrogen, Carlsbad, CA), and 8.5 day embryo
library (Invitrogen, Carlsbad CA). Mav203 yeast containing
pDEST32-Alms1C1 was grown to competency and transformed
with 10 mg of cDNA library. The transformed cells were plated
onto 50 mM 3AT SC-Leu-Trp-His agar plates and incubated at
30uC for 3 days. Colonies were replica cleaned and incubated at
30uC for 3 days. Positive colonies were tested for growth on SC-
Leu-Trp-Ura plates and for presence of lacZ on nitrocellulose
membranes. The plasmids that activated LacZ and Ura3 in
MaV203 were isolated and transformed into TOP10 Escherichia coli
(E. coli) by electroporation and plated on LB-carbenicillin plates.
Positive clones were grown at 37uC overnight in LB-carbenicillin
broth. Plasmids were isolated using Qiaprep (Qiagen, Valencia,
CA) and sequenced.
Direct Interaction assay. To further confirm the positive
interactors, the prey plasmid was transformed into MaV203 cells
with pDEST-Alms1C1. To test for false positives, the prey plasmid
was transformed back into MaV203 yeast carrying a pDBLeu
control plasmid. Smaller Alms1 constructs spanning the C-terminal
end (Alms1C2: nts 8047–8802 & Alms1C3: nts 8962–9756) were
made as described above, to delineate the binding region for
actinin.
Figure 7. Distribution of ALMS1 during cell division. (A–C)
Spatial distribution of N-terminal ALMS1 and C-terminal ALMS1 during
cytokinesis. ALMS-Ntr (A, green) is found within the centrioles at the
spindle poles. ALMS1-C (B–C, green) redistributes to the acto-myosin
contractile ring and to the cleavage furrow during late cytokinesis.
Mitotic spindles are observed by acetylated a-tubulin (red) staining.
Scale bars=5 mm.
doi:10.1371/journal.pone.0037925.g007
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Dermal fibroblasts were derived from forearm dermal explants
from four individuals with genetically confirmed ALMS, and four
control individuals as previously described [37]. The protocol was
approved by the Ethical Review Boards (Ethical Committee of
Padua Hospital and The Jackson Laboratory Institutional Review
Board for Human Subjects Research) and informed consent was
obtained from all participants. Fibroblast cultures were maintained
at 37uC/5%C02 in DMEM-C which consisted of Dulbecco’s
Modified Eagle Medium (DMEM), High glucose (4.5 g/L, Gibco,
Gaithersburg, MD) supplemented with 10%(vol/vol) fetal bovine
serum (Atlanta Biologicals, Lawrenceville, GA), 3 mg/ml L-
glutamine and 1000 U/ml penicillin/streptomycin (Gibco,
Gaithersburg, MD).
Antibodies
The following antibodies were used: Alms1-C-rabbit (1:1000),
Alms1-Ntr-rabbit (1:300; Dr. Tom Hearn), Actinin 4-rabbit
(Alexis Biochemicals, Cornerstone, CT), Actinin1-mouse (Sigma,
St. Louis, MO, EEA1-rabbit (Cell Signaling, Danvers, MA),
Pericentrin-rabbit (Covance, Princeton, NH), Rab11-rabbit (In-
vitrogen, Carlsbad, CA), transferrin-Alexa 488, transferrin re-
ceptor-mouse (Invitrogen, Carlsbad, Ca), Phalloidin-FITC (Sigma,
St. Louis, MO), ß-actin-mouse (Sigma, St. Louis, MO) and
acetylated alpha tubulin (Sigma, St. Louis, MO).
Immunocytochemistry
Fibroblasts were fixed in cold acetone or 4% paraformaldehyde
(PFA) for 15 minutes and washed briefly in phosphate buffered
saline solution (PBS). Samples were then incubated in 0.3% PBS-
Triton X (PBS-T) for 30 min, blocked with 1:50 normal horse
serum in PBS-T for 30 min. and hybridized with primary
antibody at 4uC overnight or at RT for 2 hours. Following several
washes in PBS, sections were incubated with a fluorescently-
conjugated secondary antibody (1:200) (Jackson Immuno Res,
West Grove, PA; Invitrogen, Carlsbad, CA) for 1 hour at room
temperature. Slides were washed in PBS, mounted with Vecta-
shield with DAPI (Vector Labs, Burlingame, CA) and fluorescent
staining was visualized using a Leica DMLB or a Zeiss Observer
z.1 with ApoTome microscope. For quantification of TfR in
pulsed fibroblasts, the mean fluorescence was calculated in a 2 mM
diameter area around the pericentrosomal region using ImageJ/
Fiji software (National Institutes of Health). Fluorescent intensities
were used as estimates for the number of TfR and Rab11 positive
endosomes. A total of 47 and 40 cells were used for control and
patient measurements, respectively. Statistical significance was
determined using a t-test (two-tailed). Significance was set at
*P,0.0001.
Co-Immunoprecipitation
Renal tissues from C57BL/6Ei mice were homogenized on ice
in lysis buffer (RIPA: 1% NP40, 0.5% sodium deoxycholate, 0.1%
SDS in 16PBS with Complete Mini proteinase inhibitor (Roche,
Nutley, NJ) or native buffer (50 mM Tris pH 8.0, 150 mm NaCl,
1 mM EDTA, 1% Tween-100, 0.5% NP40 and 0.1 mM sodium
vanadate) and centrifuged at 16,0006 g for 30 min. Lysates
(500 mg) were incubated with antibody (1–3 ml) at 4uC overnight.
The following day, 40 ml Protein A sepharose beads (GE
Healthcare, Pittsburg, PA) were added to the lysates and incubated
at 4uC on a rotating platform for 2 hours. Samples were washed
three times in washing buffer (50 mM Tris pH 8.0, 150 mm
NaCl, 1 mM EDTA, 1% Tween-100, 0.5% NP40 with proteinase
inhibitor), electrophoresed in a NuPage 10% Bis-Tris gel
(Invitrogen, Carlsbad, CA) and transferred to nitrocellulose
membrane. Membranes were pre-blocked in Blotto A solution
(5% milk powder, 0.05% Tween, Tris buffered saline) and
incubated at 4uC with antibody overnight. Membranes were
washed in 0.05% Tween in Tris-buffered saline (TBS-T) and
incubated with peroxidase conjugated secondary antibody for one
hour at room temperature. Following washes in TBS-T, the
immunoblots were visualized by autoradiography using the ECL
Plus Western Blotting Detection System (GE Healthcare, Pitts-
burg, PA).
Transferrin uptake and clearance in human fibroblasts
Human fibroblasts were cultured at 37uC/5% CO2, in DMEM-
C. Prior to transferrin experiments, after identical number of
passages, cells were synchronized by culturing for 1 hour at 37uC
in serum-free DMEM followed by 15 minutes in cold DMEM.
Cells were then incubated for 30 min with DMEM-C at 37uC,
washed 36with serum-free DMEM and detached from the plates
by trypsinization, (30 min, 4uC,2 mg/ml Trypsin (Sigma). Cells
were then washed 36 with pre-warmed DMEM-C immediately
before labeling. 1–2610
6 cells were allowed to internalize human
transferrin conjugated to Alexa Fluor 647 (250 mg/ml, Tf-Alexa)
(Invitrogen, Carlsbad CA) for 30 min at 37uC. After the pulse,
cells were washed twice with DMEM-C to completely remove
unbound Tf-Alexa. To measure Tf internalization, triplicate
samples were removed and immediately fixed in 4% PFA/PBS
(time zero). The remaining cells were incubated at 37uC in
DMEM-C containing unlabeled holo-transferrin (0.5 mg/ml;
Sigma-Aldrich, St. Louis, MO) for the time points indicated (cold
chase). At each time point (15, 30, and 60 minutes) triplicate
aliquots of cells were removed, washed twice with ice cold PBS and
fixed in 4% PFA/PBS at room temperature. The mean fluorescent
intensities (MFI) of the Tf-Alexa signals were captured using
a FACStar or FACScan (Becton Dickinson, Mountain View, CA).
Four separate chase experiments were pooled, the initial level of
internalized Tf-Alexa following the pulse was normalized to 100%,
and the loss of internal transferrin was measured as a reflection of
recycling to the plasma membrane. Unlabelled fibroblasts were
used as negative controls.
Statistics
Data from four independent experiments were averaged. A
linear regression analysis was used to assess the impact of patient,
time and their interaction on MFI using JMP v9.3. MFI data were
normalized to the time zero value. All assumptions of linear
regression were met. Model terms were deemed significant at a p-
value ,0.05.
Pathway and Network Analysis
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, www.
ingenuity.com) was used for the network and pathway analysis of
the Y2H data.
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